NCT03717961View on ClinicalTrials.gov

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions

Raynaud Phenomenon Secondary to Systemic Sclerosis

Interventions

DRUG

BOTOX® solution

Botox solution + Saline serum + lidocaine/prilocaine cream + Nitrous oxide/oxygen (50%/50%)

DRUG

Placebo group

Placebo + lidocaine/prilocaine cream + Nitrous oxide/oxygen (50%/50%)

Trial Locations (1)

75020

Hôpital Tenon, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03717961 - Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis | Biotech Hunter | Biotech Hunter